Application of OECD Guideline 423 in assessing the acute oral toxicity of moniliformin

Food and Chemical Toxicology

Volumn 53, Issue , 2013, Pages 27-32

  Jonsson, Martina ^a   Jestoi, Marika ^a   Nathanail, Alexis V ^a   Kokkonen, Ulla Maija ^a   Anttila, Marjukka ^a   Koivisto, Pertti ^a   Karhunen, Pirkko ^b   Peltonen, Kimmo ^a  

^a NATL VET AND FOOD RES INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Excretion; Fusarium mycotoxins; In vivo toxicity; LC MS; Moniliformin; Sprague Dawley rats

Indexed keywords

MONILIFORMIN;

ACUTE ORAL TOXICITY; ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CLINICAL FEATURE; CLINICAL OBSERVATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE SEVERITY; FECES LEVEL; HEART MUSCLE INJURY; HISTOPATHOLOGY; IN VIVO STUDY; LD 50; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MUSCLE WEAKNESS; NONHUMAN; PRACTICE GUIDELINE; RAT; RESPIRATORY DISTRESS; RISK ASSESSMENT; TARGET ORGAN; TOXICITY TESTING; TOXICOKINETICS; URINARY EXCRETION;

ADMINISTRATION, ORAL; ANIMALS; CEREALS; CHROMATOGRAPHY, LIQUID; CYCLOBUTANES; DOSE-RESPONSE RELATIONSHIP, DRUG; FECES; FOOD CONTAMINATION; FOOD MICROBIOLOGY; FUSARIUM; GUIDELINES AS TOPIC; LETHAL DOSE 50; MALE; MASS SPECTROMETRY; MYCOTOXINS; RATS; RATS, SPRAGUE-DAWLEY; TOXICITY TESTS, ACUTE;

FUSARIUM; RATTUS;

EID: 84871461818     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.11.023     Document Type: Article

References (25)

1. Abbas A., Mirocha C.J., Vesonder R.F., Gunther R. Acute toxic effects of an isolate of moniliformin-producing Fusarium oxysporum and purified moniliformin on rats. Arch. Environ. Contam. Toxicol. 1990, 19:433-436.
2. Burka L.T., Doran J., Wilson B.J. Enzyme inhibition and the toxic action of moniliformin and other vinylogous α-ketoacids. Biochem. Pharmacol. 1982, 31:79-84.
3. Burmeister H., Ciegler A., Vesonder R.F. Moniliformin, a metabolite of Fusarium moniliforme NRRL 6322: purification and toxicity. Appl. Environ. Microbiol. 1979, 37:11-13.
4. Burmeister H., Grove M., Kwolek W. Moniliformin and butenolide effect on mice of high-level, long-term oral intake. Appl. Environ. Microbiol. 1980, 40:1142-1144.
5. Cao J.L., Zhang A., Yang B., Zhang Z.T., Fu Q., Hughes C.E., Caterson B. The effect of fungal moniliformin toxin and selenium supplementation on cartilage metabolism in vitro. Osteoarthritis Cartilage 2007, 15:108.
6. Chen L., Tian X., Yang B. A study on the inhibition of rat myocardium glutathione peroxidase and glutathione reductase by moniliformin. Mycopathologia 1990, 110:119-124.
7. Deruiter J., Jarp J.M., Cutler H.G., Davis R.A. Studies on aldose reductase inhibitors from fungi. Moniliformin and small ring analogues. J. Enzyme Inhib. 1993, 7:249-256.
8. Engelhardt J.A., Carlton W.W., Tuite J.F. Toxicity of Fusarium moniliforme var subglutinans for chicks, ducklings and Turkey poults. Avian Dis. 1989, 33:357-369.
9. Fan L., Li J., Sun L. Effect of moniliformin on myocardial contractility in rats. Biomed. Environ. Sci. 1989, 4:290-294.
10. Gathercole P.S., Thiel P.G., Hofmeyr J.H. Inhibition of pyruvate dehydrogenase complex by moniliformin. Biochem. J. 1986, 233:719-723.
11. Jestoi M. Emerging Fusarium-mycotoxins fusaproliferin, beauvericin, enniatins, and moniliformin - a review. Crit. Rev. Food Sci. Nutr. 2008, 48:21-49.
12. Jestoi M., Kokkonen M., Uhlig S. What about the " other" Fusarium mycotoxins?. World Mycotoxin J. 2009, 2:181-192.
13. Kamyar M.R., Kouri K., Rawnduzi P., Studenik C., Lemmens-Gruber R. Effects of moniliformin in presence on isolated mammalian tissue and cells. Toxicol. In Vitro 2006, 20:1284-1291.
14. Kriek N.P.J., Marasas W.F.O., Steyn P.S., Van Rensburg S.J., Steyn M. Toxicity of a moniliformin-producing strain of Fusarium moniliforme var. subglutinans isolated from maize. Food Cosmet. Toxicol. 1977, 15:579-587.
15. Morgan M.K., Fitzgerald S.D., Rottinghaus G.E., Bursian S.J., Aulerich R.J. Toxic effects to mink of moniliformin extracted from Fusarium fujikuroi culture material. Vet. Hum. Toxicol. 1999, 41:1-5.
16. Nagaraj R.Y., Wu W., Will J.A., Vesonder R.F. Acute cardiotoxicity of moniliformin in broiler chickens as measured by electrocardiography. Avian Dis. 1996, 40:223-227.
17. OECD Guideline for testing of Chemicals, 2001. Guideline 423: acute Oral Toxicity - Acute Toxic Class Method 2001.
18. Peltonen K., Jestoi M., Eriksen G.S. Health effects of moniliformin: a poorly understood Fusarium mycotoxin. World Mycotoxin J. 2010, 3:403-414.
19. Pirrung M.C., Nauhaus S.K. Cofactor-directed, time-dependent inhibition of thiamine enzymes by the fungal toxin moniliformin. J. Org. Chem. 1996, 61:2592-2593.
20. Thiel P.G. A molecular mechanism for the toxic action of moniliformin, a mycotoxin produced by fusarium moniliforme. Biochem. Pharmacol. 1978, 27:483-486.
21. Ueno Y. Developments in food science. Gen. Toxicol. 1983, 4:135-146.
22. Yu S., Liu X., Wang Y., Liu J. A survey of moniliformin contamination and rice and corn from Keshan disease endemic and non-KSD areas in China. Biomed. Environ. Sci. 1995, 8:330-334.
23. Zhang A., Cao J.L., Yang B., Chen J.H., Zhang Z.-T., Li S.-Y., Fu Q., Hugnes C., Caterson B. Effects of moniliformin and selenium on human articular cartilage metabolism and their potential relationships to the pathogenesis of Kashin-Beck disease. J. Zhejiang Univ. Sci. B 2010, 11(3):200-208.
24. Zhao D., Feng Q., Yan X., Li C. Ultrastructural study of moniliformin induced lesions of myocardium in rats and mice. Biomed. Environ. Sci. 1993, 1993(6):37-44.
25. Zhu L.Z., Xia Y.M., Yang G.Q. Blood glutathione peroxidase activities of populations in Keshan disease affected and non-affected areas. Acta Nutr. Sin. 1982, 4:229-233.